COF vs IBO · P/E 62, rev $53.43B vs rev $18.0K
Capital One Financial Corporation (COF) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
COF currently screens at market cap $125.00B and trailing P/E 61.8. IBO currently screens at market cap $7.6M.
Not investment advice. Open the COF and IBO stock pages for the full models.
Not investment advice.